ResearchMoz

Top 800 Electronic Valves & Tubes (European)

Plimsoll Publishing Ltd.
Published Date » 2012-07-01
No. Of Pages » 905


This report is an in-depth financial evaluation of the EuropeanElectronic Valves & Tubes. Using the unique Plimsoll method of analysis, each of the top 800 companies included is individually assessed and ranked against each other and compared to industry averages.Using the most up-to-date financial information available, the two-page per company analysis provides detailed financial analysis for each organisation. The following are some of the key findings of this new report:

155 of the 800 companies analysed have been rated as Danger

182 companies are ripe for takeover

212 companies achieved greater than 10% increase in sales last year.

142 companies made a pre-tax loss.

322 companies saw sales fall last year
.

Our analysis gives you this unrivalled market and company intelligence using a simple graphical, numeric and model. Each company is individually analysed in both the companys own currency, and USD ($) for ease of use. These individual analyses highlight a companys strengths and weaknesses instantly.

Along with individual company information, this report also contains a comprehensive study of the market, based on the companies analysed. This key information includes
:

  • Best trading partners (based on commercial and financial strength)
  • Sales growth (highest sales, growth rate, size of market based on the companies analysed, average growth)
  • Profitability (Profit return on assets, pre-tax profit margins, industry average)
  • Fastest growing companies (performance matrix)
Companies can change at an alarming rate in a very short space of time be sure to check out the performance of the 155 companies we rate as Danger to see how these companies have declined over 4 years. The Plimsoll European Analysis will give you an in-depth assessment of the European Electronic Valves & Tubes industry instantly. Whether you wish to benchmark your own companys results, study the industry in more depth or have a vast array of industry intelligence at your disposal, this report is the ideal resource.
Table Of Contents

This extensive report is broken into two parts:


1. A complete financial assessment of the market, based on the companies analysed
2. An individual financial performance analysis of each company (2 pages per company)

Specific areas included in the market assessment include;

Section 1 - Best Trading Partners (based on commercial and financial strength)

1.1a Best Trading Partners definition and industry top 5 list
1.1b Performance matrix (Financial Strength Vs Sales Growth)
1.1c List of Best Trading Partners in the industry

Section 2 - Sales & Market Performance

2.1 Sales Growth
2.1a 4 year trend analysis
2.1b Industry Average Sales Growth
2.1c Sales Growth Ranking Table
2.1d Top 50 Companies ranked by Market Share
2.2 Sales Return on Assets
2.2a 4 year trend analysis
2.2b Sales return on total assets
2.2c Sales return on assets ranking table
2.2d Top 50 companies sales return on assets

Section 3 Profitability

3.1 Pre-tax profit margin
3.1a Pre-tax profit margin 4 year trend analysis
3.1b Industry Average pre-tax profit margin
3.1c Pre-tax profit margin ranking table
3.1d Top 50 companies actual pre-tax profit
3.2 - Pre-tax profit return on total assets
3.2a - Pre-tax profit return on total assets 4 year trend analysis
3.2b Industry average pre-tax profit return on total assets
3.2c Pre-tax profit return on total assets ranking table
3.3 - Profitability
3.3a Profitability industry average

4. 0 How to Use

5.0 Individual Company Analysis


The individual company assessment gives a complete financial picture of each company listed, including a narrative summary of the analysis. One of our key indicators is the Plimsoll Chart which combines several performance figures to give an overall measurement of the financial strength of any company. The Plimsoll chart is complied through the analysis of several different areas, including;

Sales Growth, Trading Stability, Profitability, Working Capital, Gearing and Immediate Liquidity

As all measurements are standardised, in one report you can quickly compare like with like for every major company in your industry. The accounts of each company appear in its own currency and US$ to allow comparison.

Each individual company analysis includes:

  • A full four year financial assessment, Debtor days analysis, Latest sales/profitability rankings. 
  • Employee Performance Analysis, Comparisons against industry average.
  • Overall company financial rating as read in the Plimsoll Chart, Industry ranking matrix.
  • Company analysis written summary.
Other information in the report includes;

  • Details of the Plimsoll Model
  • Definition of Terms
  • List of Shareholders
  • Global Index by region
  • Ranking Analysis by sales/profits
  • Companies considered but not included
  • Index of companies

List of Tables

NA

List of Figures

NA

Upcoming Reports:

Greece: sugar beets market
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the sugar beets market in Greece and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the sugar beets market in Greece, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate overview of the...
Biosimilars And Biosuperiors Therapeutics Antibodies Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
A biosimilar medicine possesses the similar pharmacokinetic and mode of action as an original biological medicine that has already been approved for therapeutic use. Biosimilars are made from a living organism such as bacteria and yeast or can also be derived from small molecules like human insulin, erythropoietin and monoclonal antibodies via recombinant DNA and gene expression technologies. Biosimilars are developed only when original biological medicines are commercially expired and therefore are known as follow on biologics or subsequent entry biologics. These molecules are used to...
Poland: aluminum doors market
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the aluminum doors market in Poland and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the aluminum doors market in Poland, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate overview of...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Select License type:

Share this report

Related News

Order cancellations not a sign of market slump: Airbus
Jul 31, 2014  
Leading aircraft manufacturer Airbus on Wednesday said that the recent wave of order cancellations for its commercial jetliners do not mean that the market has declined. The market is still strong and single-aisle jets deals are likely to return later. A total of 225 Airbus cancellations were reported since the beginning of this year. Of these, Dubai’s Emirates Airlines alone...
Leading Australian Universities Want to Hike Fees, Enroll Fewer Students
Jul 31, 2014  
Australia’s prestigious group of top eight universities, also known as the Group of Eight (Go8), has indicated plans of increasing tuition fees while reducing the number of students they enroll, a reform-backer has predicted. These decisions could be made if the universities are deregulated .  Arguing for this decision, the chairman of Go8, and vice chancellor of the ANU, Ian...
Blackstone Invests $800 Million in Asian Oil-Based Energy Company
Jul 31, 2014  
Blackstone Energy Partners announced to invest $800 million in an Asian based energy company that is led by former industry executives.  Blackstone is popularly considered a part of the world’s largest administrator of alternatives to financial stocks and bonds. New York-based managing director, Angelo Acconcia of Blackstone Energy Partners said in an interview that Tamarind...
Bristol-Myers Squibb Posts USD 3.9 billion Revenues in 2014 Second Quarter
Jul 30, 2014  
Leading bio-pharmaceutical company Bristol-Myers Squibb has registered revenues of USD 3.9 billion in the 2014 second quarter. This marks a 4% decrease from the same period in 2013. The global revenues of the company (excluding the divested Diabetes Alliance), saw a 7% increase. In this quarter, the company’s results were underlined by steady global sales of nearly each of its...
Novartiss Simbrinza gets approval from the EU
Jul 30, 2014  
Glaucoma patients in Europe can easily obtain Novartis’ Simbrinza eye drops which are a combination of brimonidine tartrate and brinzolamide and it is without a beta-blocker. This eye drop has got the approval of the European Commission. Unlike the inefficient treatment provided by monotherapy, this eye drop aims at treating intraocular pressure or IOP in adults with ocular hypertension...